The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.
Identifieur interne : 002A64 ( PubMed/Checkpoint ); précédent : 002A63; suivant : 002A65The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.
Auteurs : Li-Fen Chao [République populaire de Chine] ; Anthony Lin Zhang ; Hsueh-Erh Liu ; Ming-Huei Cheng ; Hung-Bun Lam ; Sing Kai LoSource :
- Breast cancer research and treatment [ 1573-7217 ] ; 2009.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Antinéoplasiques, Mastectomie.
- étiologie : Nausée, Vomissement.
- Acupression, Essais cliniques comme sujet, Femelle, Gestion de la douleur, Humains, Nausée, Points d'acupuncture, Thérapie par acupuncture, Tumeurs du sein, Vomissement.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- adverse effects : Mastectomy.
- etiology : Nausea, Vomiting.
- therapy : Breast Neoplasms, Nausea, Vomiting.
- Acupressure, Acupuncture Points, Acupuncture Therapy, Clinical Trials as Topic, Female, Humans, Pain Management.
Abstract
The aim of the present study was to scrutinize the evidence on the use of acupoint stimulation for managing therapy-related adverse events in breast cancer. A comprehensive search was conducted on eight English and Chinese databases to identify clinical trials designed to examine the efficacy of acupressure, acupuncture, or acupoint stimulation (APS) for the management of adverse events due to treatments of breast cancer. Methodological quality of the trials was assessed using a modified Jadad scale. Using pre-determined keywords, 843 possibly relevant titles were identified. Eventually 26 papers, 18 in English and eight in Chinese, satisfied the inclusion criteria and entered the quality assessment stage. The 26 articles were published between 1999 and 2008. They assessed the application of acupoint stimulation on six disparate conditions related to anticancer therapies including vasomotor syndrome, chemotherapy-induced nausea and vomiting, lymphedema, post-operation pain, aromatase inhibitors-related joint pain and leukopenia. Modalities of acupoint stimulation used included traditional acupuncture, acupressure, electroacupuncture, and the use of magnetic device on acupuncture points. Overall, 23 trials (88%) reported positive outcomes on at least one of the conditions examined. However, only nine trials (35%) were of high quality; they had a modified Jadad score of 3 or above. Three high quality trials revealed that acupoint stimulation on P6 (NeiGuang) was beneficial to chemotherapy-induced nausea and vomiting. For other adverse events, the quality of many of the trials identified was poor; no conclusive remarks can be made. Very few minor adverse events were observed, and only in five trials. APS, in particular acupressure on the P6 acupoint, appears beneficial in the management of chemotherapy-induced nausea and vomiting, especially in the acute phase. More well-designed trials using rigorous methodology are required to evaluate the effectiveness of acupoint stimulation interventions on managing other distress symptoms.
DOI: 10.1007/s10549-009-0533-8
PubMed: 19760035
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19760035Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.</title><author><name sortKey="Chao, Li Fen" sort="Chao, Li Fen" uniqKey="Chao L" first="Li-Fen" last="Chao">Li-Fen Chao</name><affiliation wicri:level="1"><nlm:affiliation>School of Nursing, Chang Gung University, Gueishan, Taoyuan, Taiwan, ROC.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>School of Nursing, Chang Gung University, Gueishan, Taoyuan, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, Anthony Lin" sort="Zhang, Anthony Lin" uniqKey="Zhang A" first="Anthony Lin" last="Zhang">Anthony Lin Zhang</name></author><author><name sortKey="Liu, Hsueh Erh" sort="Liu, Hsueh Erh" uniqKey="Liu H" first="Hsueh-Erh" last="Liu">Hsueh-Erh Liu</name></author><author><name sortKey="Cheng, Ming Huei" sort="Cheng, Ming Huei" uniqKey="Cheng M" first="Ming-Huei" last="Cheng">Ming-Huei Cheng</name></author><author><name sortKey="Lam, Hung Bun" sort="Lam, Hung Bun" uniqKey="Lam H" first="Hung-Bun" last="Lam">Hung-Bun Lam</name></author><author><name sortKey="Lo, Sing Kai" sort="Lo, Sing Kai" uniqKey="Lo S" first="Sing Kai" last="Lo">Sing Kai Lo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19760035</idno><idno type="pmid">19760035</idno><idno type="doi">10.1007/s10549-009-0533-8</idno><idno type="wicri:Area/PubMed/Corpus">002D45</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D45</idno><idno type="wicri:Area/PubMed/Curation">002D45</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D45</idno><idno type="wicri:Area/PubMed/Checkpoint">002D45</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D45</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.</title><author><name sortKey="Chao, Li Fen" sort="Chao, Li Fen" uniqKey="Chao L" first="Li-Fen" last="Chao">Li-Fen Chao</name><affiliation wicri:level="1"><nlm:affiliation>School of Nursing, Chang Gung University, Gueishan, Taoyuan, Taiwan, ROC.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>School of Nursing, Chang Gung University, Gueishan, Taoyuan, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, Anthony Lin" sort="Zhang, Anthony Lin" uniqKey="Zhang A" first="Anthony Lin" last="Zhang">Anthony Lin Zhang</name></author><author><name sortKey="Liu, Hsueh Erh" sort="Liu, Hsueh Erh" uniqKey="Liu H" first="Hsueh-Erh" last="Liu">Hsueh-Erh Liu</name></author><author><name sortKey="Cheng, Ming Huei" sort="Cheng, Ming Huei" uniqKey="Cheng M" first="Ming-Huei" last="Cheng">Ming-Huei Cheng</name></author><author><name sortKey="Lam, Hung Bun" sort="Lam, Hung Bun" uniqKey="Lam H" first="Hung-Bun" last="Lam">Hung-Bun Lam</name></author><author><name sortKey="Lo, Sing Kai" sort="Lo, Sing Kai" uniqKey="Lo S" first="Sing Kai" last="Lo">Sing Kai Lo</name></author></analytic><series><title level="j">Breast cancer research and treatment</title><idno type="eISSN">1573-7217</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acupressure</term><term>Acupuncture Points</term><term>Acupuncture Therapy</term><term>Antineoplastic Agents (adverse effects)</term><term>Breast Neoplasms (therapy)</term><term>Clinical Trials as Topic</term><term>Female</term><term>Humans</term><term>Mastectomy (adverse effects)</term><term>Nausea (etiology)</term><term>Nausea (therapy)</term><term>Pain Management</term><term>Vomiting (etiology)</term><term>Vomiting (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acupression</term><term>Antinéoplasiques (effets indésirables)</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Gestion de la douleur</term><term>Humains</term><term>Mastectomie (effets indésirables)</term><term>Nausée ()</term><term>Nausée (étiologie)</term><term>Points d'acupuncture</term><term>Thérapie par acupuncture</term><term>Tumeurs du sein ()</term><term>Vomissement ()</term><term>Vomissement (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Mastectomie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Nausea</term><term>Vomiting</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Nausea</term><term>Vomiting</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Nausée</term><term>Vomissement</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acupressure</term><term>Acupuncture Points</term><term>Acupuncture Therapy</term><term>Clinical Trials as Topic</term><term>Female</term><term>Humans</term><term>Pain Management</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acupression</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Gestion de la douleur</term><term>Humains</term><term>Nausée</term><term>Points d'acupuncture</term><term>Thérapie par acupuncture</term><term>Tumeurs du sein</term><term>Vomissement</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of the present study was to scrutinize the evidence on the use of acupoint stimulation for managing therapy-related adverse events in breast cancer. A comprehensive search was conducted on eight English and Chinese databases to identify clinical trials designed to examine the efficacy of acupressure, acupuncture, or acupoint stimulation (APS) for the management of adverse events due to treatments of breast cancer. Methodological quality of the trials was assessed using a modified Jadad scale. Using pre-determined keywords, 843 possibly relevant titles were identified. Eventually 26 papers, 18 in English and eight in Chinese, satisfied the inclusion criteria and entered the quality assessment stage. The 26 articles were published between 1999 and 2008. They assessed the application of acupoint stimulation on six disparate conditions related to anticancer therapies including vasomotor syndrome, chemotherapy-induced nausea and vomiting, lymphedema, post-operation pain, aromatase inhibitors-related joint pain and leukopenia. Modalities of acupoint stimulation used included traditional acupuncture, acupressure, electroacupuncture, and the use of magnetic device on acupuncture points. Overall, 23 trials (88%) reported positive outcomes on at least one of the conditions examined. However, only nine trials (35%) were of high quality; they had a modified Jadad score of 3 or above. Three high quality trials revealed that acupoint stimulation on P6 (NeiGuang) was beneficial to chemotherapy-induced nausea and vomiting. For other adverse events, the quality of many of the trials identified was poor; no conclusive remarks can be made. Very few minor adverse events were observed, and only in five trials. APS, in particular acupressure on the P6 acupoint, appears beneficial in the management of chemotherapy-induced nausea and vomiting, especially in the acute phase. More well-designed trials using rigorous methodology are required to evaluate the effectiveness of acupoint stimulation interventions on managing other distress symptoms.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19760035</PMID><DateCreated><Year>2009</Year><Month>10</Month><Day>20</Day></DateCreated><DateCompleted><Year>2009</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2011</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-7217</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Breast cancer research and treatment</Title><ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation></Journal><ArticleTitle>The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.</ArticleTitle><Pagination><MedlinePgn>255-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-009-0533-8</ELocationID><Abstract><AbstractText>The aim of the present study was to scrutinize the evidence on the use of acupoint stimulation for managing therapy-related adverse events in breast cancer. A comprehensive search was conducted on eight English and Chinese databases to identify clinical trials designed to examine the efficacy of acupressure, acupuncture, or acupoint stimulation (APS) for the management of adverse events due to treatments of breast cancer. Methodological quality of the trials was assessed using a modified Jadad scale. Using pre-determined keywords, 843 possibly relevant titles were identified. Eventually 26 papers, 18 in English and eight in Chinese, satisfied the inclusion criteria and entered the quality assessment stage. The 26 articles were published between 1999 and 2008. They assessed the application of acupoint stimulation on six disparate conditions related to anticancer therapies including vasomotor syndrome, chemotherapy-induced nausea and vomiting, lymphedema, post-operation pain, aromatase inhibitors-related joint pain and leukopenia. Modalities of acupoint stimulation used included traditional acupuncture, acupressure, electroacupuncture, and the use of magnetic device on acupuncture points. Overall, 23 trials (88%) reported positive outcomes on at least one of the conditions examined. However, only nine trials (35%) were of high quality; they had a modified Jadad score of 3 or above. Three high quality trials revealed that acupoint stimulation on P6 (NeiGuang) was beneficial to chemotherapy-induced nausea and vomiting. For other adverse events, the quality of many of the trials identified was poor; no conclusive remarks can be made. Very few minor adverse events were observed, and only in five trials. APS, in particular acupressure on the P6 acupoint, appears beneficial in the management of chemotherapy-induced nausea and vomiting, especially in the acute phase. More well-designed trials using rigorous methodology are required to evaluate the effectiveness of acupoint stimulation interventions on managing other distress symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Li-Fen</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>School of Nursing, Chang Gung University, Gueishan, Taoyuan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Anthony Lin</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hsueh-Erh</ForeName><Initials>HE</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Ming-Huei</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Hung-Bun</ForeName><Initials>HB</Initials></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Sing Kai</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Breast Cancer Res Treat</MedlineTA><NlmUniqueID>8111104</NlmUniqueID><ISSNLinking>0167-6806</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019050" MajorTopicYN="Y">Acupressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015669" MajorTopicYN="Y">Acupuncture Points</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015670" MajorTopicYN="Y">Acupuncture Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>70</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>08</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19760035</ArticleId><ArticleId IdType="doi">10.1007/s10549-009-0533-8</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Cheng, Ming Huei" sort="Cheng, Ming Huei" uniqKey="Cheng M" first="Ming-Huei" last="Cheng">Ming-Huei Cheng</name><name sortKey="Lam, Hung Bun" sort="Lam, Hung Bun" uniqKey="Lam H" first="Hung-Bun" last="Lam">Hung-Bun Lam</name><name sortKey="Liu, Hsueh Erh" sort="Liu, Hsueh Erh" uniqKey="Liu H" first="Hsueh-Erh" last="Liu">Hsueh-Erh Liu</name><name sortKey="Lo, Sing Kai" sort="Lo, Sing Kai" uniqKey="Lo S" first="Sing Kai" last="Lo">Sing Kai Lo</name><name sortKey="Zhang, Anthony Lin" sort="Zhang, Anthony Lin" uniqKey="Zhang A" first="Anthony Lin" last="Zhang">Anthony Lin Zhang</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Chao, Li Fen" sort="Chao, Li Fen" uniqKey="Chao L" first="Li-Fen" last="Chao">Li-Fen Chao</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A64 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002A64 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19760035
|texte= The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19760035" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |